The effect of the use of misoprostol on the efficiency of MR-HIFU treatment in women with symptomatic uterine fibroids

Not Applicable

• Conditions: D25; Leiomyoma of uterus

• Registration Number: DRKS00017841
• Lead Sponsor: Pro-Familia Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2018-09-27
• Study Start: 2019-09-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Symptomatic uterus fibroids, fertility disorder

Exclusion Criteria

Size of fibroid >13 cm, asymptomatic fibroids, MR contraindications

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of NPV (non-perfused volume) after treatment. Evaluation of time of treatments. NPV is measured after injecting radiological contrast fluid, and NPV is used to determine the area of the necrosis in the tumor. The Duration of each treatment consisted of only the sonication time.

Secondary Outcome Measures

Name	Time	Method
Evaluation of volume of fibroids in MR scanner 6 MTh after treatment.